ProCE Banner Activity

Phase III Myeloma XI: Response-Adapted Induction Improves Outcomes in Newly Diagnosed Multiple Myeloma

Slideset Download
Conference Coverage
Response-adapted use of sequential IMiD- and PI-based induction therapy improves response depth and PFS in newly diagnosed multiple myeloma.

Released: December 06, 2016

Expiration: December 05, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Seagen